封面
市场调查报告书
商品编码
1882095

全球血清移植诊断市场

Serological Transplant Diagnostics

出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 161 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

全球血清移植诊断市场预计到2030年将达到20亿美元。

全球血清移植诊断市场规模预计在2024年为12亿美元,到2030年将达到20亿美元,在分析期间(2024-2030年)内复合年增长率(CAGR)为8.6%。本报告分析的试剂和配件细分市场预计将以9.2%的复合年增长率成长,并在分析期结束时达到16亿美元。系统细分市场预计在分析期间将以6.4%的复合年增长率成长。

美国市场规模估计为3.251亿美元,而中国市场预计将以12.1%的复合年增长率成长。

预计到2024年,美国血清移植诊断市场规模将达到3.251亿美元。作为世界第二大经济体,中国预计到2030年市场规模将达到4.467亿美元,在2024年至2030年的分析期内,复合年增长率(CAGR)将达到12.1%。其他值得关注的区域市场包括日本和加拿大,预计在分析期内,这两个市场的复合年增长率将分别达到6.4%和6.5%。在欧洲,德国的复合年增长率预计将达到约6.7%。

全球血清移植诊断市场—主要趋势与驱动因素概述

为什么血清学诊断在移植医学中如此重要

血清学移植诊断在移植医学中至关重要,在确保捐赠者相容性和预防移植排斥方面发挥关键作用。这些诊断包括人类白血球抗原 (HLA) 抗体检测、血型鑑定和交叉配对试验,用于评估捐赠者之间的免疫相容性。由于末期器官疾病病例的增加,器官移植的需求日益增长,推动了血清学诊断在提高移植成功率和改善患者预后的应用。此外,市场也受到对早期准确检测供体特异性抗体 (DSA) 和其他免疫标记的日益重视的推动,因为这些检测有助于临床医生就免疫抑制治疗和移植后护理做出明智的决策。

技术进步如何改善移植领域的血清诊断?

技术创新显着提升了移植领域血清学诊断的能力,并提高了准确性、灵敏度和自动化程度。用于HLA型检测和交叉配对试验的自动化平台和多重检测方法的开发缩短了检测结果报告时间,并提高了移植中心的效率。流式细胞技术、Luminex技术和次世代定序(NGS)的应用实现了高解析度HLA型检测,有助于提高捐赠者配型的准确性,并降低移植排斥的风险。人工智慧和机器学习演算法在移植诊断中的应用提供了预测分析和决策支援工具,帮助临床医生更有效地管理移植患者。此外,非侵入性诊断工具和无细胞DNA检测技术的进步已成为监测移植排斥反应的有效方法,减少了侵入性切片检查的需求。

哪些细分市场正在推动血清移植诊断技术的应用?

血清学移植诊断市场按检测类型、应用领域、最终用户和地区进行细分。检测类型包括HLA型检测、交叉配对试验和抗体筛检。 HLAHLA型检测最为广泛,在确保相容性和降低移植排斥率方面发挥关键作用。应用领域包括肾臟、肝臟、心臟、肺臟和其他器官移植。由于末期肾功能衰竭的高发病率和活体肾源的充足,肾臟移植是最大的细分市场。最终用户包括医院、移植中心、研究实验室和诊断实验室。医院和移植中心需要快速且准确的诊断结果,因此是主要使用者。按地区划分,北美和欧洲凭藉其先进的医疗基础设施和较高的移植率引领市场,而亚太地区由于器官移植项目数量的增加和医疗费用支出的增长,正在崛起为一个高增长市场。

推动血清移植诊断市场成长的关键因素有哪些?

血清学移植诊断市场的成长受多种因素驱动,包括器官移植需求的不断增长、自动化和多重诊断平台的进步,以及对早期准确检测免疫标记的日益重视。高解析度HLA型检测、抗体筛检和交叉配对技术的进步,使得检测结果更加精准快速,加速了这些技术在移植中心和医院的应用。对非侵入性诊断和个人化免疫抑制疗法的日益重视,正在扩大移植后监测和患者管理领域的市场范围。透过先进的血清学诊断提高移植成功率和降低移植物排斥反应,为市场成长创造了新的机会。此外,对下一代血清学诊断、人工智慧驱动的预测分析以及用于移植排斥反应监测的无细胞DNA检测等研发投入的增加,也进一步推动了市场的扩张。

部分:

产品类型(试剂及配件、系统)、应用(肾臟移植、肝臟移植、心臟移植、肺移植、其他应用)、最终用途(医院、血库、移植中心、其他最终用途)

受访公司范例

  • Agena Bioscience, Inc.
  • Avioq, Inc.
  • Bag Health Care GmbH
  • Beckman Coulter, Inc.
  • Becton, Dickinson &Company
  • Biocell Medicare
  • Biogenuix Medsystems Pvt. Ltd.
  • Bio-Rad Laboratories, Inc.
  • DIAGAST
  • Grifols SA
  • Hemo bioscience, Inc.
  • Immucor, Inc.
  • Institut de Biotechnologies Jacques Boy SAS
  • Lorne Laboratories Ltd.
  • MTC med. Produkte GmbH
  • Ortho Clinical Diagnostics
  • Quotient Biodiagnostics
  • REAGENS Kft.
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc.
  • Tulip Ltd.

人工智慧集成

我们正在利用检验的专家内容和人工智慧工具,革新市场和竞争情报分析。

Market Glass, Inc. 并没有采用查询LLM 或产业专用的SLM 的典型方法,而是建立了一个由世界各地领域专家精心策划的内容库,其中包括视频转录、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

在最新发布的报告中,Market Glass, Inc. 将关税对地理市场的影响纳入考量,并根据公司总部所在国、製造地以及进出口(成品和OEM产品)情况,预测企业竞争格局的变化。这种复杂多变的市场现实将对竞争对手产生多方面的影响,包括销货成本增加、盈利下降和供应链重组,同时也会影响微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 亚太其他地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP14675

Global Serological Transplant Diagnostics Market to Reach US$2.0 Billion by 2030

The global market for Serological Transplant Diagnostics estimated at US$1.2 Billion in the year 2024, is expected to reach US$2.0 Billion by 2030, growing at a CAGR of 8.6% over the analysis period 2024-2030. Reagents & Accessories, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$1.6 Billion by the end of the analysis period. Growth in the Systems segment is estimated at 6.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$325.1 Million While China is Forecast to Grow at 12.1% CAGR

The Serological Transplant Diagnostics market in the U.S. is estimated at US$325.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$446.7 Million by the year 2030 trailing a CAGR of 12.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.4% and 6.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.7% CAGR.

Global Serological Transplant Diagnostics Market - Key Trends and Drivers Summarized

Why Are Serological Diagnostics Critical in Transplant Medicine?

Serological transplant diagnostics are crucial in transplant medicine, playing a vital role in ensuring donor-recipient compatibility and preventing graft rejection. These diagnostics involve testing for human leukocyte antigen (HLA) antibodies, blood typing, and crossmatching to assess the immunological compatibility between donors and recipients. The rising demand for organ transplants, driven by increasing cases of end-stage organ diseases, is fueling the adoption of serological diagnostics to improve transplant success rates and patient outcomes. The emphasis on early and accurate detection of donor-specific antibodies (DSAs) and other immunological markers is further driving the market, as these tests help clinicians make informed decisions on immunosuppressive therapies and post-transplant care.

How Are Technological Advancements Enhancing Serological Diagnostics in Transplants?

Technological advancements are significantly enhancing the capabilities of serological diagnostics in transplants, making them more accurate, sensitive, and automated. The development of automated platforms and multiplex assays for HLA typing and crossmatching is reducing turnaround times and improving the efficiency of transplant centers. The use of flow cytometry, Luminex technology, and next-generation sequencing (NGS) is enabling high-resolution HLA typing, facilitating better donor-recipient matching and minimizing the risk of graft rejection. The integration of AI and machine learning algorithms in transplant diagnostics is providing predictive analytics and decision support tools, helping clinicians manage transplant patients more effectively. Additionally, advancements in non-invasive diagnostic tools and cell-free DNA testing are emerging as promising approaches for monitoring allograft rejection, reducing the need for invasive biopsies.

Which Market Segments Are Leading the Adoption of Serological Transplant Diagnostics?

The serological transplant diagnostics market is segmented by test type, application, end-user, and region. Test types include HLA typing, crossmatching, and antibody screening, with HLA typing being the most widely adopted due to its critical role in ensuring compatibility and reducing transplant rejection rates. Applications span kidney, liver, heart, lung, and other organ transplants, with kidney transplants being the largest segment due to the high prevalence of end-stage renal disease and the availability of living donors. End-users include hospitals, transplant centers, research laboratories, and diagnostic laboratories, with hospitals and transplant centers being the primary adopters due to the need for rapid and accurate diagnostic results. Geographically, North America and Europe lead the market for serological transplant diagnostics due to advanced healthcare infrastructure and high transplant rates, while Asia-Pacific is emerging as a high-growth market driven by increasing organ transplantation programs and rising healthcare expenditure.

What Are the Key Drivers of Growth in the Serological Transplant Diagnostics Market?

The growth in the serological transplant diagnostics market is driven by several factors, including the increasing demand for organ transplants, advancements in automated and multiplex diagnostic platforms, and the rising focus on early and accurate detection of immunological markers. The development of high-resolution HLA typing, antibody screening, and crossmatching technologies that provide precise and rapid results is driving market adoption among transplant centers and hospitals. The growing emphasis on non-invasive diagnostics and personalized immunosuppressive therapies is expanding the market reach in post-transplant monitoring and patient management. The shift towards improving transplant success rates and reducing graft rejection through advanced serological diagnostics is creating new opportunities for market growth. Additionally, the increasing investments in R&D for next-generation serological diagnostics, AI-driven predictive analytics, and cell-free DNA testing for transplant rejection monitoring are further supporting market expansion.

SCOPE OF STUDY:

The report analyzes the Serological Transplant Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Reagents & Accessories, Systems); Application (Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation, Other Applications); End-Use (Hospitals, Blood Banks, Transplant Centers, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 18 Featured) -

  • Agena Bioscience, Inc.
  • Avioq, Inc.
  • Bag Health Care GmbH
  • Beckman Coulter, Inc.
  • Becton, Dickinson & Company
  • Biocell Medicare
  • Biogenuix Medsystems Pvt. Ltd.
  • Bio-Rad Laboratories, Inc.
  • DIAGAST
  • Grifols SA
  • Hemo bioscience, Inc.
  • Immucor, Inc.
  • Institut de Biotechnologies Jacques Boy S.A.S.
  • Lorne Laboratories Ltd.
  • MTC med. Produkte GmbH
  • Ortho Clinical Diagnostics
  • Quotient Biodiagnostics
  • REAGENS Kft.
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc.
  • Tulip Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Global Economic Update
    • Serological Transplant Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Accurate and Reliable Transplant Compatibility Testing Drives Market for Serological Transplant Diagnostics
    • Technological Advancements in HLA Typing and Crossmatching Propel Innovation in Serological Diagnostics
    • Increasing Use of Serological Diagnostics in Kidney, Liver, Heart, and Lung Transplantation Expands Addressable Market Opportunity
    • Growth of Organ Transplantation Programs and Registries Strengthens Business Case for Serological Diagnostics
    • Challenges Related to Limited Availability of Donors and Ethical Issues Pose Market Constraints
    • Focus on Enhancing Sensitivity, Specificity, and Turnaround Time of Serological Tests Drives Market Adoption
    • Emergence of Automated and High-Throughput Serological Testing Platforms Generates New Market Opportunities
    • Rising Demand for Non-Invasive and Minimally Invasive Transplant Diagnostics Boosts Market Potential
    • Shift Towards Personalized Transplant Medicine and Immunogenetics Expands Market Reach
    • Growing Emphasis on Allograft Rejection Monitoring and Post-Transplant Care Spurs Market Innovation
    • Emergence of Serological Diagnostics as a Key Tool for Reducing Graft Rejection Rates Expands Adoption
    • Rising Number of Transplant Centers and Organ Sharing Networks Creates New Opportunities for Serological Diagnostics
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Serological Transplant Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Serological Transplant Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Serological Transplant Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Reagents & Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Reagents & Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Reagents & Accessories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Kidney Transplantation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Kidney Transplantation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Kidney Transplantation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Liver Transplantation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Liver Transplantation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Liver Transplantation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Heart Transplantation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Heart Transplantation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Heart Transplantation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Lung Transplantation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Lung Transplantation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Lung Transplantation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Blood Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Blood Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Blood Banks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Transplant Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Transplant Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Transplant Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Serological Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Serological Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Serological Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Serological Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Serological Transplant Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Serological Transplant Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Serological Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Serological Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Serological Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Spain 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Russia 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Serological Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Serological Transplant Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Serological Transplant Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Serological Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Australia 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Serological Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 170: India Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: India 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: South Korea 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Serological Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Serological Transplant Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Serological Transplant Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Latin America 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Argentina 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Brazil 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Mexico 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Serological Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Serological Transplant Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Serological Transplant Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Middle East 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Iran 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Israel 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: UAE 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Serological Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 310: Africa 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION